Storia in 3 fonti

Ozempic maker Novo Nordisk's board slims down as directors quit

The departures followed a disagreement between the board and its majority shareholder over future governance.

Raccontata da

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

bbc.comStai leggendo10 mesi fa

The departures followed a disagreement between the board and its majority shareholder over future governance.

cnbc.com10 mesi fa

Novo Nordisk directors and the firm's controlling shareholder failed to reach an agreement on the future composition of the board.